[Overdose of yellow fever vaccine in the Southern region of Brazil]
- PMID: 21552746
- DOI: 10.1590/s0037-86822011000200025
[Overdose of yellow fever vaccine in the Southern region of Brazil]
Abstract
Introduction: Yellow fever is a preventable disease when using a safe, effective vaccine.
Methods: A prospective clinical follow-up of 49 people who received an overdose of the wrong vaccine against yellow fever during the 2009 outbreak in a rural area of the Vale do Rio Pardo, State of Rio Grande do Sul.
Results: During 45 days of clinical follow-up, only 1 (2.1%) case presented manifestations of a possible acute viscerotropism as an adverse postvaccination event.
Conclusions: In the group of people monitored following an overdose of anti-yellow fever vaccine, observation confirmed almost total absence of adverse events.
Similar articles
-
Yellow Fever outbreaks in unvaccinated populations, Brazil, 2008-2009.PLoS Negl Trop Dis. 2014 Mar 13;8(3):e2740. doi: 10.1371/journal.pntd.0002740. eCollection 2014 Mar. PLoS Negl Trop Dis. 2014. PMID: 24625634 Free PMC article.
-
Adverse events following yellow fever immunization: Report and analysis of 67 neurological cases in Brazil.Vaccine. 2014 Nov 20;32(49):6676-82. doi: 10.1016/j.vaccine.2014.05.003. Epub 2014 May 14. Vaccine. 2014. PMID: 24837504
-
Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005.Vaccine. 2007 Apr 20;25(16):3124-8. doi: 10.1016/j.vaccine.2007.01.078. Epub 2007 Jan 30. Vaccine. 2007. PMID: 17316927
-
Yellow fever: epidemiology and prevention.Clin Infect Dis. 2007 Mar 15;44(6):850-6. doi: 10.1086/511869. Epub 2007 Feb 1. Clin Infect Dis. 2007. PMID: 17304460 Review.
-
Yellow fever vaccine safety: a reality or a myth?Vaccine. 2002 Nov 1;20(31-32):3627-8. doi: 10.1016/s0264-410x(02)00409-7. Vaccine. 2002. PMID: 12399186 Review.
Cited by
-
17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study.Hum Vaccin Immunother. 2013 Apr;9(4):879-88. doi: 10.4161/hv.22982. Epub 2013 Jan 30. Hum Vaccin Immunother. 2013. PMID: 23364472 Free PMC article. Clinical Trial.
-
Yellow fever vaccine and risk of developing serious adverse events: a systematic review.Rev Panam Salud Publica. 2018 Jun 5;42:e75. doi: 10.26633/RPSP.2018.75. eCollection 2018. Rev Panam Salud Publica. 2018. PMID: 31093103 Free PMC article. Review.
-
Notes from the Field: Errors in Administration of an Excess Dosage of Yellow Fever Vaccine - United States, 2017.MMWR Morb Mortal Wkly Rep. 2018 Jan 26;67(3):109-110. doi: 10.15585/mmwr.mm6703a6. MMWR Morb Mortal Wkly Rep. 2018. PMID: 29370153 Free PMC article. No abstract available.
-
Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007-2017.Vaccine. 2019 Jun 19;37(28):3730-3734. doi: 10.1016/j.vaccine.2019.04.088. Epub 2019 May 30. Vaccine. 2019. PMID: 31155414 Free PMC article.
-
Serious adverse events associated with yellow fever vaccine.Hum Vaccin Immunother. 2015;11(9):2183-7. doi: 10.1080/21645515.2015.1022700. Hum Vaccin Immunother. 2015. PMID: 26090855 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources